Proto Labs, Inc. (NYSE:PRLB) Given Consensus Rating of “Moderate Buy” by Analysts

Shares of Proto Labs, Inc. (NYSE:PRLBGet Free Report) have been given an average rating of “Moderate Buy” by the five ratings firms that are covering the stock, Marketbeat Ratings reports. One analyst has rated the stock with a hold rating and four have given a buy rating to the company. The average twelve-month target price among brokers that have issued a report on the stock in the last year is $65.3333.

Several analysts have issued reports on the stock. Weiss Ratings raised shares of Proto Labs from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Friday. Zacks Research cut Proto Labs from a “strong-buy” rating to a “hold” rating in a research note on Friday, July 3rd. Benchmark raised their price target on Proto Labs from $70.00 to $91.00 and gave the stock a “buy” rating in a research note on Thursday, July 2nd. Finally, Wall Street Zen lowered Proto Labs from a “strong-buy” rating to a “buy” rating in a research note on Saturday.

Check Out Our Latest Stock Analysis on Proto Labs

Insiders Place Their Bets

In other news, Director Sven Wehrwein sold 2,000 shares of the business’s stock in a transaction on Tuesday, June 2nd. The shares were sold at an average price of $77.28, for a total transaction of $154,560.00. Following the completion of the sale, the director directly owned 32,505 shares of the company’s stock, valued at approximately $2,511,986.40. The trade was a 5.80% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Michael R. Kenison sold 16,030 shares of the company’s stock in a transaction dated Tuesday, May 12th. The stock was sold at an average price of $69.49, for a total transaction of $1,113,924.70. Following the completion of the transaction, the insider owned 18,683 shares in the company, valued at approximately $1,298,281.67. The trade was a 46.18% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last quarter, insiders sold 25,663 shares of company stock worth $1,804,727. Insiders own 1.30% of the company’s stock.

Institutional Investors Weigh In On Proto Labs

Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Group One Trading LLC purchased a new stake in Proto Labs in the 4th quarter valued at about $25,000. NewEdge Advisors LLC increased its position in shares of Proto Labs by 7,380.0% during the first quarter. NewEdge Advisors LLC now owns 748 shares of the industrial products company’s stock worth $26,000 after acquiring an additional 738 shares during the period. NBC Securities Inc. bought a new stake in shares of Proto Labs during the fourth quarter valued at approximately $46,000. Modus Advisors LLC bought a new stake in shares of Proto Labs during the fourth quarter valued at approximately $57,000. Finally, Aquatic Capital Management LLC bought a new stake in shares of Proto Labs during the third quarter valued at approximately $64,000. Institutional investors own 84.54% of the company’s stock.

Proto Labs Stock Up 0.5%

Proto Labs stock opened at $77.78 on Friday. The firm’s fifty day moving average is $75.88 and its 200 day moving average is $65.01. The company has a market cap of $1.85 billion, a price-to-earnings ratio of 73.38 and a beta of 1.38. Proto Labs has a 52-week low of $38.48 and a 52-week high of $83.15.

Proto Labs (NYSE:PRLBGet Free Report) last announced its quarterly earnings results on Friday, May 1st. The industrial products company reported $0.54 EPS for the quarter, beating analysts’ consensus estimates of $0.40 by $0.14. Proto Labs had a net margin of 4.71% and a return on equity of 4.15%. The firm had revenue of $139.34 million during the quarter, compared to the consensus estimate of $135.31 million. During the same quarter last year, the firm earned $0.33 EPS. The firm’s revenue for the quarter was up 10.4% compared to the same quarter last year. Proto Labs has set its Q2 2026 guidance at 0.500-0.580 EPS. On average, equities research analysts anticipate that Proto Labs will post 1.37 earnings per share for the current fiscal year.

About Proto Labs

(Get Free Report)

Proto Labs, Inc is a digital manufacturing company that offers on-demand production services for custom parts and prototypes. Utilizing technologies such as 3D printing (additive manufacturing), CNC machining and injection molding, the company transforms digital CAD designs into functional parts on accelerated timelines. Its platform-driven process combines automated quoting, rapid tool generation and manufacturing execution to serve product developers, engineers and small- to medium-sized production runs.

Founded in 1999 by Larry Lukis, Proto Labs has championed the application of digital workflows to traditional manufacturing methods.

Featured Articles

Analyst Recommendations for Proto Labs (NYSE:PRLB)

Receive News & Ratings for Proto Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Proto Labs and related companies with MarketBeat.com's FREE daily email newsletter.